254 related articles for article (PubMed ID: 34155062)
1. TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Cordido A; Nuñez-Gonzalez L; Martinez-Moreno JM; Lamas-Gonzalez O; Rodriguez-Osorio L; Perez-Gomez MV; Martin-Sanchez D; Outeda P; Chiaravalli M; Watnick T; Boletta A; Diaz C; Carracedo A; Sanz AB; Ortiz A; Garcia-Gonzalez MA
J Am Soc Nephrol; 2021 Aug; 32(8):1913-1932. PubMed ID: 34155062
[TBL] [Abstract][Full Text] [Related]
2. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
Armstrong CL; Galisteo R; Brown SA; Winkles JA
Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
Zhu C; Zhang L; Liu Z; Li C; Bai Y
J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction.
Unudurthi SD; Nassal DM; Patel NJ; Thomas E; Yu J; Pierson CG; Bansal SS; Mohler PJ; Hund TJ
Life Sci; 2020 Apr; 247():117440. PubMed ID: 32070706
[TBL] [Abstract][Full Text] [Related]
5. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury.
Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A
Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384
[TBL] [Abstract][Full Text] [Related]
6. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
7. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways.
Di Martino L; Osme A; Kossak-Gupta S; Pizarro TT; Cominelli F
Cell Mol Gastroenterol Hepatol; 2019; 8(3):427-446. PubMed ID: 31181286
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells.
Chen J; Jia F; Ren K; Luo M; Min X; Wang P; Xiao S; Xia Y
Cell Signal; 2020 Jul; 71():109615. PubMed ID: 32217132
[TBL] [Abstract][Full Text] [Related]
9. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
[TBL] [Abstract][Full Text] [Related]
10. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
12. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
14. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
15. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.
Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
[TBL] [Abstract][Full Text] [Related]
17. Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury.
Guerrero-Hue M; Vallejo-Mudarra M; García-Caballero C; Córdoba-David GM; Palomino-Antolín A; Herencia C; Vendrell-Casana B; Rubio-Navarro A; Egido J; Blanco-Colio LM; Moreno JA
Biomed Pharmacother; 2023 Dec; 169():115925. PubMed ID: 38007933
[TBL] [Abstract][Full Text] [Related]
18. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.
Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM
EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
Ding H; Li LX; Harris PC; Yang J; Li X
Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
[TBL] [Abstract][Full Text] [Related]
20. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
